The U.S. Vaccines business unit is a critical strategic pillar of Pfizer’s commercial portfolio, representing the largest collective impact on population health and substantial contribution to enterprise revenues and earnings. Our Vaccines protect millions of lives every year across every stage of life. Our inline and pipeline products represent a key part of Pfizer’s renewed strategy for 2030 and beyond. Today, U.S. Vaccines are largely administered within two ‘traditional’ channels – at point of care (in HCP offices and health systems) and via retail pharmacy. However, driven by numerous factors, vaccination rates have consistently fallen year over year in the past 5 years, culminating in double-digit declines in the latest northern hemisphere winter ‘season’ of administrations. At the same time, intense competition across categories and the involvement of multiple intermediary actors are driving pricing erosion, placing significant pressure on vaccine margins and limiting ability to reinvest in the next generation of breakthrough vaccines. To meet the urgency this moment demands, US Vaccines has established a priority ‘Go to Market Innovation’ program, led by a Pilot in Command, under executive sponsorship by the U.S. Commercial Division, U.S. Primary Care and U.S. Vaccines, tasked with establishing transformative routes to market that will appropriately increase vaccine administration rates and sustain vaccines innovation. This role will drive marketing, awareness, and operational execution that bring initiatives to life in the market which include pilots now and the next wave of channels as the strategy scales. This role will report into Susan Schneps (PIC).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior